Financials in USD. Standardized financial statements.
A compact view of how CSAM Health Group AS turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue? | $424.96M | $410.46M | $366.67M | $329.30M | $228.54M | $23.61M |
| Revenue Growth? | +3.5% | +11.9% | +11.3% | +44.1% | +868.1% | 0.0% |
| Cost of Revenue? | $31.03M | $32.01M | $33.38M | $35.37M | $25.68M | $12.02M |
| Gross Profit? | $393.93M | $378.45M | $333.29M | $293.94M | $202.85M | $11.59M |
| Gross Margin? | +92.7% | +92.2% | +90.9% | +89.3% | +88.8% | +49.1% |
| Operating Expenses? | $397.06M | $249.76M | $423.74M | $335.76M | $185.59M | $13.76M |
| Operating Income? | -$3.14M | $128.69M | -$90.45M | -$41.82M | $17.26M | -$2.17M |
| EBITDA? | $56.15M | $227.88M | -$10.27M | $21.24M | $58.18M | $4.11M |
| Income Before Tax | -$60.08M | $103.37M | -$136.33M | -$89.11M | -$8.01M | -$4.01M |
| Income Tax Expense | -$789,000 | -$8.35M | -$4.73M | -$2.55M | $1.22M | $120,634 |
| Net Income? | -$59.29M | $104.35M | -$131.60M | -$86.56M | -$9.23M | -$4.13M |
| EPS? | $-2.94 | $5.11 | $-6.29 | $-4.13 | $-0.44 | $-0.20 |
| Diluted EPS? | $-2.94 | $5.11 | $-6.29 | $-4.13 | $-0.44 | $-0.20 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality